PX1 Research provides certified, high-purity Gonadorelin for qualified laboratory and in vitro research applications. Engineered for rigorous scientific standards, every batch undergoes independent RP-HPLC and mass spectrometry testing to guarantee sequence integrity and purity. Sourcing high-grade compounds ensures baseline reproducibility across preclinical endocrine models.
PX1 Research provides certified, high-purity Gonadorelin for qualified laboratory and in vitro research applications. Engineered for rigorous scientific standards, every batch undergoes independent RP-HPLC and mass spectrometry testing to guarantee sequence integrity and purity. Sourcing high-grade compounds ensures baseline reproducibility across preclinical endocrine models.
To buy gonadorelin for scientific research, principal investigators and laboratory technicians require verified, high-purity synthetic gonadotropin-releasing hormone (GnRH) manufactured under stringent analytical standards. PX1 Research supplies USA-manufactured, lyophilized gonadorelin featuring lot-specific certificates of analysis (COA), comprehensive RP-HPLC testing, mass spectrometry verification, and verified endotoxin limits for preclinical in vitro and animal assays.
When purchasing reagents for sensitive endocrine signaling studies, raw purity and lot-to-lot consistency are critical variables. Impurities or degraded fragments can alter receptor binding affinity, leading to skewed experimental data in gonadotropin secretion assays. PX1 Research mitigates these risks by producing research compounds in domestic, GMP-compliant facilities under strict quality management systems.
Investigators seeking to order gonadorelin research peptide can rely on PX1 Research for rapid fulfillment. Orders ship same-day (Monday through Friday) from centralized distribution centers in California and Arizona, ensuring minimal transit exposure and optimal structural stability upon delivery to your laboratory facility.
Gonadorelin is a synthetic decapeptide identical in sequence to endogenous gonadotropin-releasing hormone (GnRH), also referred to as luteinizing hormone-releasing hormone (LHRH). Its primary primary structure consists of ten amino acids: Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycinamide (pyr-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2). It possesses a molecular formula of C55H75N17O13 and a precise molecular mass of approximately 1182.3 g/mol.
The molecular architecture of Gonadorelin features distinct functional domains. The N-terminal pyroglutamyl and histidyl residues are critical for receptor activation and signal transduction, while the C-terminal glycinamide modification confers structural stabilization against immediate carboxypeptidase degradation in aqueous media. Understanding these structural parameters is vital when modeling ligand-receptor interaction dynamics in computer-aided drug design or in vitro binding assays.
In contrast to modified GnRH analogues that incorporate D-amino acid substitutions to extend half-life, standard Gonadorelin maintains the native L-configuration sequence. This structural identity makes it the preferred benchmark compound when evaluating fundamental physiological responses, baseline GnRH receptor (GnRHR) kinetics, and receptor internalizing pathways within academic research setups across our catalog of high-purity peptides.
In preclinical models, Gonadorelin functions as a full agonist at the gonadotropin-releasing hormone receptor (GnRHR), a seven-transmembrane domain G-protein coupled receptor located primarily on the cell membranes of anterior pituitary gonadotropes. Binding of Gonadorelin to GnRHR initiates a signaling cascade coupled to the Gαq/11 protein complex.
This receptor engagement activates phospholipase C (PLC), which subsequently hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into two key intracellular second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the rapid release of intracellular calcium (Ca2+) from the endoplasmic reticulum, while DAG activates protein kinase C (PKC) isoforms. Together, elevated intracellular Ca2+ levels and PKC activation drive the transcription and exocytosis of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Preclinical literature demonstrates that the mode of Gonadorelin administration alters receptor dynamics. In vitro assays utilizing pulsatile exposure show sustained synthesis and release of LH and FSH without receptor desensitization. Conversely, continuous superfusion of Gonadorelin induces GnRHR down-regulation, receptor internalization, and subsequent suppression of gonadotropin secretion. This dual response renders Gonadorelin an essential reference compound for studying receptor trafficking, desensitization kinetics, and feedback control mechanisms within the hypothalamic-pituitary-gonadal (HPG) axis.
Gonadorelin is extensively utilized across a broad spectrum of in vitro and animal research paradigms focused on reproductive endocrinology, neuroendocrinology, and cellular signaling. Because its structure replicates natural GnRH, it serves as an indispensable physiological control in comparative studies.
In cell culture investigations, primary pituitary cell models and immortalized gonadotrope cell lines (such as LβT2 or αT3-1 cells) are routinely treated with Gonadorelin to measure gene expression changes. Investigators analyze the transcriptional regulation of LHβ, FSHβ, and glycoprotein α-subunits using quantitative real-time PCR (qPCR) and Western blotting. These studies help elucidate how pulse frequency and amplitude encode differential gene expression patterns.
Animal research models also employ Gonadorelin to evaluate neuroendocrine response mechanisms. Rodent and non-human primate studies utilize controlled exposures to map the downstream effects of HPG axis activation on gonadal steroidogenesis, hypothalamic feedback loops, and pituitary sensitivity. Researchers interested in exploring related pathways can review our broader gonadotropin-releasing hormone research repository for technical literature.
When designing GnRHR-targeted experiments, laboratory researchers must choose between native-sequence Gonadorelin and modified GnRH superagonists. Native Gonadorelin exhibits a rapid clearance rate and short biological half-life, making it ideal for transient, pulsatile stimulation protocols where immediate reversibility is required.
In contrast, synthetic superagonists incorporate structural modifications—such as D-amino acid substitutions at position 6 or ethylamide modifications at the C-terminus—that drastically increase enzymatic resistance and receptor affinity. For instance, triptorelin features a D-Tryptophan substitution at position 6, yielding substantially higher potency and prolonged receptor occupancy. Similarly, compounds such as buserelin and leuprolide acetate demonstrate extended plasma stability, making them preferred choices for experiments designed to achieve sustained pituitary desensitization rather than acute pulsatile signaling.
Choosing between these molecules depends entirely on the experimental model. While superagonists are tailored for chronic receptor down-regulation studies, Gonadorelin remains the gold standard for dissecting native, physiological GnRHR signaling and immediate second-messenger cascades without inducing unintended prolonged refractoriness.
High-reproducibility scientific research requires strict chemical verification of all input reagents. Unverified peptides containing synthesis side-products, truncated sequences, or residual TFA (trifluoroacetic acid) salts can yield confounding data in bioassays and cell culture systems. PX1 Research enforces a multi-tier analytical protocol for every batch of Gonadorelin.
Identity and structural integrity are validated using Electrospray Ionization Mass Spectrometry (ESI-MS) to ensure the observed molecular weight precisely matches the theoretical mass of 1182.3 Da. Purity is quantified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a minimum purity profile of ≥98.0%. HPLC chromatograms are included in every lot-specific Certificate of Analysis.
Furthermore, biological assays sensitivity requires strict contamination control. PX1 Research subjects all peptide lots to Chromogenic Recombinant LAL (Limulus Amebocyte Lysate) assay testing to verify that bacterial endotoxin levels remain strictly below <0.1 EU/mg. All testing is conducted through ISO 17025 accredited independent third-party laboratories to guarantee uncompromised quality before shipment.
Gonadorelin is supplied as a lyophilized (freeze-dried) sterile powder to maximize shelf life and structural stability during storage and shipping. To preserve peptide integrity during laboratory handling, strict aseptic techniques and specific reconstitution protocols must be observed.
Prior to reconstitution, the vial should be allowed to equilibrate to room temperature to minimize condensation inside the container. For in vitro and cell culture applications, the peptide powder should be reconstituted using sterile, cell-culture-grade water or phosphate-buffered saline (PBS, pH 7.4). If long-term aqueous storage of working stock solutions is necessary, adding a carrier protein such as 0.1% Bovine Serum Albumin (BSA) can prevent non-specific peptide adsorption to glass or plastic container walls.
Avoid vigorous vortexing or mechanical agitation during reconstitution, as shear forces can disrupt peptide secondary structures and cause aggregation. Gentle swirling or passive dissolution is recommended. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which accelerate peptide degradation.
Proper temperature control is essential for maintaining the chemical stability of synthetic peptides over extended durations. Unreconstituted lyophilized Gonadorelin powder should be stored in a freezer at -20°C for short-to-medium term storage, or at -80°C for long-term preservation exceeding six months. Under these desiccated, sub-zero conditions, the compound remains stable for up to two years.
Once reconstituted into aqueous solution, Gonadorelin is significantly more susceptible to hydrolytic cleavage and enzymatic degradation. Working solutions prepared in sterile buffer can be kept at 4°C for short-term use (up to 7 days). For extended storage of reconstituted material, aliquots must be frozen at -20°C or -80°C and used immediately upon thawing.
Vials should be protected from light exposure and stored in sealed containers containing a desiccant. Comprehensive stability guidelines and technical documentation can be accessed through our analytical purity documentation library.
For university departments, biotechnology organizations, and contract research organizations (CROs), supply chain security and batch consistency are essential. PX1 Research operates state-of-the-art domestic manufacturing facilities adhering to strict Good Manufacturing Practice (GMP) guidelines.
Domestic USA production eliminates international shipping delays, customs holds, and cold-chain breakdowns that risk degrading sensitive peptide reagents. Every shipment originates from our facilities in California or Arizona, providing consistent logistics performance and same-day dispatch for orders placed before cutoff times.
Institutional purchasing agents and laboratory managers requiring high-volume supplies or specialized custom synthesis options can establish direct procurement channels via our wholesale research accounts portal, ensuring dedicated account support and volume-tiered pricing.
What is the certified purity level of PX1 Research Gonadorelin?
Every lot of Gonadorelin supplied by PX1 Research is verified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to maintain a chemical purity profile of ≥98.0%.
How is Gonadorelin identity confirmed analytical testing?
Identity is validated using Electrospray Ionization Mass Spectrometry (ESI-MS) to verify that the experimental molecular weight matches the exact theoretical molecular weight (1182.3 g/mol) of the intact decapeptide.
What are the endotoxin specifications for PX1 Research compounds?
PX1 Research peptides undergo chromogenic LAL endotoxin testing to ensure levels remain below <0.1 EU/mg, preventing endotoxin-induced interference in sensitive cell culture and in vitro assays.
How should lyophilized Gonadorelin be stored upon receipt?
Lyophilized Gonadorelin powder should be stored at -20°C upon arrival for medium-term storage, or at -80°C for long-term storage, protected from light and moisture.
What solvent is recommended for reconstituting Gonadorelin for laboratory assays?
Gonadorelin dissolves readily in sterile cell-culture-grade water or standard Phosphate-Buffered Saline (PBS, pH 7.4). For micro-molar working stocks, adding 0.1% BSA helps reduce surface adsorption.
How does Gonadorelin differ structurally from superagonist peptides like Triptorelin?
Gonadorelin retains the exact native 10-amino-acid sequence of endogenous GnRH, whereas superagonists like Triptorelin feature modified D-amino acids (e.g., D-Trp6) to enhance potency and plasma half-life.
Where are PX1 Research peptide compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic, GMP-compliant facilities in the USA and shipped directly from distribution hubs located in California and Arizona.
Can academic and corporate research facilities set up bulk or wholesale procurement?
Yes, qualified academic institutions, biotechnology companies, and contract research facilities can establish wholesale accounts through PX1 Research for bulk quantities and recurring lab orders.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.